We are live on
!
Find out more
Two Sigma Advisers Portfolio holdings
AUM
$51.4B
1-Year Est. Return
31.07%
This Fund
S&P 500
This Quarter
Est. Return
-2.68%
1 Year Est. Return
+31.07%
3 Year Est. Return
+128.94%
5 Year Est. Return
+161.75%
10 Year Est. Return
+607.04%
AUM
$39B
AUM Growth
-$220M
(-0.56%)
Cap. Flow
+$1.59B
Cap. Flow
% of AUM
4.06%
Top 10 Holdings %
Top 10 Hldgs %
16.38%
Holding
2,663
New
306
Increased
844
Reduced
1,189
Closed
301
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$592M |
| 2 |
Tesla
TSLA
|
+$492M |
| 3 |
Amazon
AMZN
|
+$474M |
| 4 |
Advanced Micro Devices
AMD
|
+$410M |
| 5 |
Qualcomm
QCOM
|
+$358M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SCHW
Charles Schwab
SCHW
|
+$393M |
| 2 |
Union Pacific
UNP
|
+$363M |
| 3 |
Walmart Inc
WMT
|
+$239M |
| 4 |
Citigroup
C
|
+$192M |
| 5 |
ConocoPhillips
COP
|
+$172M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.84% |
| 2 | Healthcare | 15.27% |
| 3 | Consumer Discretionary | 13.96% |
| 4 | Industrials | 10.47% |
| 5 | Financials | 8.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2326
Playboy Inc
PLBY
$141M
| $18.5K | ﹤0.01% |
23,100
-500
| -2% | -$717 |
|
2327
Eledon Pharmaceuticals
ELDN
$262M
| $17.9K | ﹤0.01% |
13,100
-9,900
| -43% | -$13.2K |
|
2328
Forte Biosciences
FBRX
$1.57B
| $17.9K | ﹤0.01% |
1,080
-1,224
| -53% | -$27.1K |
|
2329
Kaltura
KLTR
$217M
| $17.6K | ﹤0.01% |
+10,200
| New | +$20.1K |
|
|
PLG
2330
Platinum Group Metals
PLG
$159M
| $16.6K | ﹤0.01% |
14,700
-4,700
| -24% | -$6.04K |
|
2331
GigaMedia
GIGM
$15M
| $15.9K | ﹤0.01% |
11,800
| – | – |
|
2332
Atossa Therapeutics
ATOS
$24.1M
| $15.7K | ﹤0.01% |
1,420
-407
| -22% | -$5.9K |
|
|
FTH
2333
Faeth Therapeutics
FTH
$751M
| $15.5K | ﹤0.01% |
970
-275
| -22% | -$5.91K |
|
|
CRDL
2334
Cardiol Therapeutics
CRDL
$138M
| $15.1K | ﹤0.01% |
16,900
| – | – |
|
2335
BARK
BARK
$78.4M
| $14.3K | ﹤0.01% |
595
-505
| -46% | -$14K |
|
|
SNCE
2336
DELISTED
Science 37 Holdings, Inc. Common Stock
SNCE
| $14K | ﹤0.01% |
+1,750
| New | +$10.4K |
|
2337
Clover Health Investments
CLOV
$2.28B
| $13.8K | ﹤0.01% |
+12,800
| New | +$15.2K |
|
|
LTRPA
2338
DELISTED
Liberty TripAdvisor Holdings, Inc. Series A
LTRPA
| $12.9K | ﹤0.01% |
26,400
-5,500
| -17% | -$3.56K |
|
|
NVTA
2339
DELISTED
Invitae Corporation
NVTA
| $12.6K | ﹤0.01% |
20,900
-25,900
| -55% | -$26.9K |
|
|
STRR
2340
DELISTED
Star Equity Holdings
STRR
| $12.2K | ﹤0.01% |
2,487
-653
| -21% | -$3.31K |
|
2341
Westwater Resources
WWR
$51.6M
| $11.8K | ﹤0.01% |
17,700
-16,100
| -48% | -$12.3K |
|
2342
Assembly Biosciences
ASMB
$507M
| $11.5K | ﹤0.01% |
1,083
-159
| -13% | -$1.92K |
|
2343
Presidio Property Trust
SQFT
$3.01M
| $11.1K | ﹤0.01% |
1,400
-110
| -7% | -$935 |
|
|
CASA
2344
DELISTED
Casa Systems, Inc. Common Stock
CASA
| $10K | ﹤0.01% |
11,800
-41,800
| -78% | -$40.6K |
|
|
SHCR
2345
DELISTED
Sharecare, Inc. Class A Common Stock
SHCR
| $9.4K | ﹤0.01% |
+10,000
| New | +$11.9K |
|
2346
Newegg Commerce
NEGG
$295M
| $9.22K | ﹤0.01% |
545
-150
| -22% | -$3.48K |
|
2347
Perspective Therapeutics
CATX
$327M
| $8.92K | ﹤0.01% |
3,260
-360
| -10% | -$1.68K |
|
2348
Regis Corp
RGS
$68.2M
| $8.65K | ﹤0.01% |
615
-505
| -45% | -$11.1K |
|
|
BLPH
2349
DELISTED
Bellerophon Therapeutics, Inc.
BLPH
| $8.55K | ﹤0.01% |
21,500
+6,600
| +44% | +$3.25K |
|
|
SOLO
2350
DELISTED
Electrameccanica Vehicles Corp. Ltd.
SOLO
| $7.93K | ﹤0.01% |
12,100
-1,800
| -13% | -$1.3K |
|
Similar funds
CWM
VRS
FAF
BGIM
CIM
PPFA
Two Sigma Advisers's Q3 2023 Portfolio in Review
As of Q3 2023, Two Sigma Advisers held 2,663 positions worth $39B, down 0.56% from $39.3B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Two Sigma Advisers deployed $1.59B of net new capital in Q3 2023, opening 306 new positions and adding to 844 existing holdings. Its largest new stake was Advanced Micro Devices: 3,777,240 shares worth $388M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 23% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was Charles Schwab, an estimated $393M trimmed.
- Two Sigma Advisers's largest Q3 2023 buy was Advanced Micro Devices: 3,777,240 shares worth $388M.
- Two Sigma Advisers added most to Microsoft in Q3 2023, an estimated $592M increase.
- Two Sigma Advisers's biggest Q3 2023 reduction was Charles Schwab, cutting an estimated $393M.
- Two Sigma Advisers fully exited Uber in Q3 2023, selling an estimated $109M.
- Two Sigma Advisers's ten largest holdings make up 16% of its $39B portfolio in Q3 2023.
- Two Sigma Advisers opened 306 new positions and closed 301 in Q3 2023.
- Two Sigma Advisers's portfolio value fell 0.56% quarter-over-quarter to $39B.
Based on Two Sigma Advisers's 13F filing for Q3 2023, filed 14 Nov 2023.